Board of Directors

Richard S. Bodman (Chairman)

Richard (Dick) Bodman is an entrepreneurial businessman and investor. Dick is also Managing General Partner of VMS Group, which performs administrative & advisory services for venture capital funds, and General Manager of Bodman Oil & Gas, LLC.

Dick served as the Assistant Secretary of the U.S. Department of the Interior, and subsequently as Assistant Director of the Office of Management and Budget in The White House. After government service, he joined DuPont and served in several management positions in Textile Fibers and Corporate Finance. He then joined the Communications Satellite Corporation as CFO and subsequently served as President & CEO of Comsat General Corporation and President of Satellite Television Corporation. He later joined AT&T as Senior VP for Strategy & Development where he co-founded AT&T Ventures, and in 1996 he simultaneously acquired AT&T Ventures and became its Co-Managing Partner, retiring from AT&T.

Dick is also currently Chairman of the Board of Telecom Development Fund. Earlier board service included Reed Elsevier, Young & Rubicam, Internet Security Systems, Lin Broadcasting, Tyco International, National Housing Partnerships, Sandia National Laboratories, Boys & Girls Clubs of America, Morristown Hospital System and Naples Community Healthcare System. He received a B.S. in Engineering from Princeton University, and an M.S. in Industrial Management from M.I.T. He was a CPA and Partner at Touche Ross & Co.

Lisa T. Grimes

Lisa T. Grimes is President and Chief Executive Officer of PurThread Technologies Inc. Lisa has spent the majority of her 28-year career in sales, marketing, and executive management in the healthcare industry. She is the former CEO of InSite Clinical Trials, a site management organization that was acquired by United Healthcare.

In addition, Lisa has previously served as Vice President of Business Development for Pharmaceutical Product Development (Nasdaq:PPDI). She was as a member of the Executive Advisory Group of Campbell Alliance and its subsidiary, the Pharmaceutical Institute for ten years. Lisa has also served as CEO of AcSentient, a specialty pharmacy company focused on ophthalmics, and Angiomics, an anti-angiogenesis company.

She is Chairman of the Board of Directors of Lighthouse Ministries and is immediate past Chair of The Caring Community Foundation (a local cancer charity). Lisa graduated from the School of Pharmacy at the University of North Carolina at Chapel Hill.

Neal M. Douglas

Neal is an experienced businessman and investor. He has been a Venture Partner at the Telecom Development Fund since 2005. From December 1999 to October 2003, Neal served as the Managing General Partner of Spectrum Equity Investors, L.P., a venture capital firm investing exclusively in the communications industry. Neal was a co-founder of AT&T Ventures, the venture capital affiliate of AT&T Corporation, and has served as a General Partner since January 1993. From May 1989 to January 1993, Neal was a partner of New Enterprise Associates. Prior to this, he was an investment professional with Crosspoint Venture Partners and was a member of the technical staff at Bell Laboratories.

Neal has been involved in financing many communications companies, including Juniper Networks, VeriSign, Covad Communications, Ascend Communications, Software.com, TUT Systems, and Netro. Neal holds a B.S. in Electrical Engineering from Cornell University, an M.S. from Stanford University, and an M.B.A. from the University of California at Los Angeles.

Tom Inglesby, MD

Dr. Inglesby is Director of the UPMC Center for Health Security and Associate Professor of Medicine and Public Health at the University of Pittsburgh Schools of Medicine and Public Health. Dr. Inglesby’s work is internationally recognized in the fields of public health preparedness, pandemic flu planning, and biosecurity. He is Chair of the Board of Scientific Counselors, Office of Public Health Preparedness and Response, of the US Centers for Disease Control and Prevention. Dr. Inglesby has been chair or a member of a number of National Academy of Sciences committees; and he has served in an advisory capacity to the Defense Science Board, the Departments of Health and Human Services and Homeland Security, and the National Institutes of Health.

Since 1999, Dr. Inglesby has authored or co-authored more than 80 peer-reviewed articles, reports, and commentaries on a wide range of public health and national security issues. He is Coeditor-in-Chief of the journal Biosecurity and Bioterrorism: Biodefense Strategy, Practice, and Science, which he helped to establish in 2003 as the first peer-reviewed journal in its field. In addition, Dr. Inglesby was principal editor of the 2002 JAMA book Bioterrorism: Guidelines for Medical and Public Health Management.
He completed his internal medicine and infectious diseases training at Johns Hopkins University School of Medicine, where he also served as Assistant Chief of Service in 1996-97. Dr. Inglesby received his MD from Columbia University College of Physicians and Surgeons and his BA from Georgetown University.